| Literature DB >> 26290104 |
Nicholas V DiPatrizio1, Miki Igarashi2, Vidya Narayanaswami2, Conor Murray2, Joseph Gancayco2, Amy Russell2, Kwang-Mook Jung2, Daniele Piomelli3.
Abstract
The endocannabinoids are lipid-derived signaling molecules that control feeding and energy balance by activating CB1-type cannabinoid receptors in the brain and peripheral tissues. Previous studies have shown that oral exposure to dietary fat stimulates endocannabinoid signaling in the rat small intestine, which provides positive feedback that drives further food intake and preference for fat-rich foods. We now describe an unexpectedly broader role for cholinergic signaling of the vagus nerve in the production of the endocannabinoid, 2-arachidonoyl-sn-glycerol (2-AG), in the small intestine. We show that food deprivation increases levels of 2-AG and its lipid precursor, 1,2-diacylglycerol, in rat jejunum mucosa in a time-dependent manner. This response is abrogated by surgical resection of the vagus nerve or pharmacological blockade of small intestinal subtype-3 muscarinic acetylcholine (m3 mAch) receptors, but not inhibition of subtype-1 muscarinic acetylcholine (m1 mAch). We further show that blockade of peripheral CB1 receptors or intestinal m3 mAch receptors inhibits refeeding in fasted rats. The results suggest that food deprivation stimulates 2-AG-dependent CB1 receptor activation through a mechanism that requires efferent vagal activation of m3 mAch receptors in the jejunum, which, in turn, may promote feeding after a fast.Entities:
Keywords: cannabinoid receptor type 1 (CB1); cholinergic receptor; endocannabinoid; gut-brain; vagus nerve
Mesh:
Substances:
Year: 2015 PMID: 26290104 PMCID: PMC4666947 DOI: 10.1152/ajpregu.00239.2015
Source DB: PubMed Journal: Am J Physiol Regul Integr Comp Physiol ISSN: 0363-6119 Impact factor: 3.619